CA2235511A1 - Process for the preparation of a growth hormone secretagogue - Google Patents

Process for the preparation of a growth hormone secretagogue Download PDF

Info

Publication number
CA2235511A1
CA2235511A1 CA002235511A CA2235511A CA2235511A1 CA 2235511 A1 CA2235511 A1 CA 2235511A1 CA 002235511 A CA002235511 A CA 002235511A CA 2235511 A CA2235511 A CA 2235511A CA 2235511 A1 CA2235511 A1 CA 2235511A1
Authority
CA
Canada
Prior art keywords
compound
formula
acid
amino
protecting group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002235511A
Other languages
English (en)
French (fr)
Inventor
Peter G. Houghton
Ioannis Houpis
Audrey Molina
Joseph E. Lynch
Ralph P. Volante
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9602949.1A external-priority patent/GB9602949D0/en
Application filed by Individual filed Critical Individual
Publication of CA2235511A1 publication Critical patent/CA2235511A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002235511A 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue Abandoned CA2235511A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US589895P 1995-10-27 1995-10-27
US60/005,898 1995-10-27
GBGB9602949.1A GB9602949D0 (en) 1996-02-13 1996-02-13 Process for the preparation of a growth hormone secretagogue
GB9602949.1 1996-02-13
PCT/US1996/016954 WO1997015573A1 (en) 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue

Publications (1)

Publication Number Publication Date
CA2235511A1 true CA2235511A1 (en) 1997-05-01

Family

ID=26308687

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002235511A Abandoned CA2235511A1 (en) 1995-10-27 1996-10-23 Process for the preparation of a growth hormone secretagogue

Country Status (14)

Country Link
EP (1) EP0863900A1 (hu)
JP (1) JPH11513984A (hu)
KR (1) KR19990067097A (hu)
AR (1) AR004124A1 (hu)
AU (1) AU7468596A (hu)
BR (1) BR9610887A (hu)
CA (1) CA2235511A1 (hu)
CZ (1) CZ128298A3 (hu)
HR (1) HRP960494A2 (hu)
HU (1) HUP9902095A3 (hu)
PL (1) PL326428A1 (hu)
SK (1) SK51198A3 (hu)
WO (1) WO1997015573A1 (hu)
YU (1) YU56596A (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
WO1998018815A1 (en) * 1996-10-25 1998-05-07 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
US6828331B1 (en) 1999-02-19 2004-12-07 Eli Lilly And Company Growth hormone secretagogues
ES2333097T3 (es) 2000-05-31 2010-02-17 Raqualia Pharma Inc Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
US7125840B2 (en) 2001-10-09 2006-10-24 Eli Lilly And Company Substituted dipeptides as growth hormone secretagogues
WO2003087069A2 (en) 2002-04-09 2003-10-23 Eli Lilly And Company Dipeptidic growth hormone secretagogues
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
KR20090107088A (ko) 2007-02-09 2009-10-12 트랜자임 파르마 인크 거대고리 그렐린 수용체 조절제 및 이의 사용 방법
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL176993B1 (pl) * 1992-12-11 1999-08-31 Merck & Co Inc Nowe związki spiropiperydynowe oraz sposób ich wytwarzania

Also Published As

Publication number Publication date
SK51198A3 (en) 1998-11-04
KR19990067097A (ko) 1999-08-16
AR004124A1 (es) 1998-09-30
YU56596A (sh) 1999-09-27
EP0863900A1 (en) 1998-09-16
MX9803316A (es) 1998-09-30
JPH11513984A (ja) 1999-11-30
BR9610887A (pt) 1999-07-13
CZ128298A3 (cs) 1998-07-15
HUP9902095A3 (en) 2001-05-28
AU7468596A (en) 1997-05-15
HRP960494A2 (en) 1998-04-30
PL326428A1 (en) 1998-09-14
WO1997015573A1 (en) 1997-05-01
HUP9902095A2 (hu) 1999-10-28

Similar Documents

Publication Publication Date Title
US5622973A (en) Treatment of osteoporosis with substituted piperidines, pyrrolidines and hexahydro-1H-azepines in combination with bisphosphonates
US5723616A (en) Process for the preparation of a growth hormone secretagogue
JP2509530B2 (ja) 成長ホルモンの放出を促進するスピロピペリジン及び同族体
US5767124A (en) Polymorphic forms of a growth hormone secretagogue
US5804578A (en) Piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
CA2235511A1 (en) Process for the preparation of a growth hormone secretagogue
FR2575753A1 (fr) Nouveaux derives peptidiques a structure polycyclique azotee, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20130059791A1 (en) Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium slat of d-isoglutamyl-d-tryptophan
WO1994015956A1 (en) Endothelin converting enzyme inhibitors
US5880125A (en) 4-spiroindoline piperidines promote release of growth hormone
US5965565A (en) Piperidines promote release of growth hormone
US6046333A (en) Convergent process for the preparation of a growth hormone secretagogue
WO1998018815A1 (en) Convergent process for the preparation of a growth hormone secretagogue
PL131155B1 (en) Process for preparing novel peptides
EP0823904A1 (en) Process for the preparation of spiroindolines
CA2379282C (en) Amido spiropiperidines promote the release of growth hormone
US4691008A (en) Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process
US6028196A (en) Process for the preparation of a growth hormone secretagogue
US7615571B2 (en) Process for manufacture of pure (2S, 3aS, 7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl) butyl]amino]-1-oxopropyl] octahydro-1H-indole-2-carboxylic acid and its tert. butyl amine salt
WO1993006127A1 (en) Novel amino acid prodrug renin inhibitors
MXPA98003316A (en) Procedure for preparing a secretagogo de hormona de crecimie
US4031069A (en) Tetrapeptides
JPS59225182A (ja) 2−アゼチジノン−4−カルボン酸の誘導体
AU707946B2 (en) Polymorphic forms of a growth hormone secretagogue
US3931138A (en) N-carbobenzoxy-pyroglutamyl-histidine

Legal Events

Date Code Title Description
FZDE Discontinued